Brief history of medicine in Japan

28 November 2016
japan-minstry-logo-big

It is likely some readers of this article are of the opinion that Japan is a tough market to crack, says P Reed Maurer, long-time Japan pharma watcher and president of International Alliances Limited in an exclusive article for The Pharma Letter.

They see or imagine barriers designed to keep foreigners out, or at least bias the rules in favor of insiders. Throughout this brief history of medicine you may see confirmation of your assumptions, or not. Best to keep an open mind.

The first Westerners to arrive in Japan were some Portuguese sailors blown ashore at Tanegashima in 1542. Interesting to note this is the same site used today to launch Japanese rockets and hardware into space. Saint Francis Xavier, an intrepid missionary, arrived in 1549. Americans did not arrive until 1853, 300 years after the Europeans.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical